| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 221 | 217 | 244 | 223 | 217 | 237 | 263 | 298 | 207 | 368 | 304 | 341 | |
Growth YoY Revenue Growth YoY% | 38.1 | 3.4 | 33.6 | 12.0 | -1.5 | 9.4 | 7.7 | 34.0 | -4.6 | 55.1 | 15.6 | 14.3 |
| 185 | 188 | 212 | 192 | 191 | 210 | 269 | 295 | 206 | 338 | 290 | 317 | |
| 35 | 29 | 32 | 30 | 26 | 28 | -6 | 3 | 2 | 30 | 14 | 24 | |
OPM OPM% | 16.0 | 13.3 | 13.3 | 13.6 | 12.1 | 11.8 | -2.1 | 1.0 | 0.8 | 8.2 | 4.6 | 7.1 |
| 8 | 13 | 8 | 8 | 8 | 4 | 12 | 12 | -2 | 8 | 2 | 18 | |
Interest Expense Interest ExpenseCr | 4 | 3 | 4 | 3 | 4 | 4 | 2 | 3 | 3 | 2 | 2 | 4 |
Depreciation DepreciationCr | 9 | 8 | 8 | 9 | 9 | 9 | 11 | 11 | 9 | 11 | 11 | 11 |
PBT PBTCr | 30 | 30 | 28 | 26 | 22 | 19 | -7 | 1 | -12 | 25 | 3 | 27 |
| 0 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 30 | 34 | 28 | 26 | 22 | 19 | -7 | 1 | -12 | 25 | 3 | 27 | |
Growth YoY PAT Growth YoY% | 348.6 | -43.4 | 162.2 | 29.4 | -25.6 | -42.9 | -124.4 | -94.3 | -154.1 | 29.9 | 137.4 | 1,704.0 |
NPM NPM% | 13.7 | 15.4 | 11.6 | 11.6 | 10.3 | 8.1 | -2.6 | 0.5 | -5.9 | 6.7 | 0.8 | 7.9 |
| 6.2 | 6.8 | 5.8 | 5.4 | 4.1 | 4.4 | -0.9 | -0.1 | -2.5 | 4.3 | 0.5 | 4.8 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 221 | 217 | 244 | 223 | 217 | 237 | 263 | 298 | 207 | 368 | 304 | 341 | |
Growth YoY Revenue Growth YoY% | 38.1 | 3.4 | 33.6 | 12.0 | -1.5 | 9.4 | 7.7 | 34.0 | -4.6 | 55.1 | 15.6 | 14.3 |
| 185 | 188 | 212 | 192 | 191 | 210 | 269 | 295 | 206 | 338 | 290 | 317 | |
| 35 | 29 | 32 | 30 | 26 | 28 | -6 | 3 | 2 | 30 | 14 | 24 | |
OPM OPM% | 16.0 | 13.3 | 13.3 | 13.6 | 12.1 | 11.8 | -2.1 | 1.0 | 0.8 | 8.2 | 4.6 | 7.1 |
| 8 | 13 | 8 | 8 | 8 | 4 | 12 | 12 | -2 | 8 | 2 | 18 | |
Interest Expense Interest ExpenseCr | 4 | 3 | 4 | 3 | 4 | 4 | 2 | 3 | 3 | 2 | 2 | 4 |
Depreciation DepreciationCr | 9 | 8 | 8 | 9 | 9 | 9 | 11 | 11 | 9 | 11 | 11 | 11 |
PBT PBTCr | 30 | 30 | 28 | 26 | 22 | 19 | -7 | 1 | -12 | 25 | 3 | 27 |
| 0 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 30 | 34 | 28 | 26 | 22 | 19 | -7 | 1 | -12 | 25 | 3 | 27 | |
Growth YoY PAT Growth YoY% | 348.6 | -43.4 | 162.2 | 29.4 | -25.6 | -42.9 | -124.4 | -94.3 | -154.1 | 29.9 | 137.4 | 1,704.0 |
NPM NPM% | 13.7 | 15.4 | 11.6 | 11.6 | 10.3 | 8.1 | -2.6 | 0.5 | -5.9 | 6.7 | 0.8 | 7.9 |
| 6.2 | 6.8 | 5.8 | 5.4 | 4.1 | 4.4 | -0.9 | -0.1 | -2.5 | 4.3 | 0.5 | 4.8 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 873 | 797 | 683 | 600 | 484 | 450 | 560 | 666 | 819 | 1,398 | 1,233 | 1,221 |
Growth Revenue Growth% | -50.0 | -8.8 | -14.3 | -12.2 | -19.4 | -7.0 | 24.3 | 19.0 | 23.1 | 70.6 | -11.8 | 20.1 |
| 703 | 804 | 667 | 618 | 456 | 400 | 506 | 582 | 709 | 1,253 | 1,199 | 1,151 | |
| 171 | -8 | 16 | -18 | 28 | 50 | 53 | 84 | 111 | 144 | 34 | 70 | |
OPM OPM% | 19.6 | -0.9 | 2.3 | -3.0 | 5.8 | 11.1 | 9.5 | 12.6 | 13.5 | 10.3 | 2.7 | 5.7 |
| -28 | -59 | 20 | 218 | 24 | 15 | 9 | 59 | 31 | 32 | 29 | 26 | |
Interest Expense Interest ExpenseCr | 294 | 336 | 302 | 0 | 4 | 51 | 32 | 32 | 16 | 13 | 9 | 11 |
Depreciation DepreciationCr | 145 | 141 | 133 | 130 | 118 | 109 | 87 | 55 | 33 | 42 | 43 | 42 |
PBT PBTCr | -296 | -544 | -399 | 69 | -70 | -95 | -57 | 55 | 92 | 122 | 10 | 42 |
| -17 | -48 | -46 | 0 | 0 | 0 | 0 | 0 | -3 | -10 | 0 | 0 | |
PAT PATCr | -279 | -495 | -353 | 69 | -70 | -95 | -57 | 55 | 95 | 131 | 11 | 42 |
Growth PAT Growth% | -41.6 | -77.5 | 28.8 | 119.7 | -200.4 | -36.7 | 40.3 | 197.1 | 72.1 | 38.0 | -91.9 | 16.5 |
NPM NPM% | -32.0 | -62.2 | -51.6 | 11.6 | -14.4 | -21.2 | -10.2 | 8.3 | 11.6 | 9.4 | 0.9 | 3.5 |
| -32.1 | -55.7 | -39.6 | 7.8 | -14.8 | -28.6 | -0.5 | 11.3 | 19.1 | 19.6 | 1.7 | 7.1 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 873 | 797 | 683 | 600 | 484 | 450 | 560 | 666 | 819 | 1,398 | 1,233 | 1,221 |
Growth Revenue Growth% | -50.0 | -8.8 | -14.3 | -12.2 | -19.4 | -7.0 | 24.3 | 19.0 | 23.1 | 70.6 | -11.8 | 20.1 |
| 703 | 804 | 667 | 618 | 456 | 400 | 506 | 582 | 709 | 1,253 | 1,199 | 1,151 | |
| 171 | -8 | 16 | -18 | 28 | 50 | 53 | 84 | 111 | 144 | 34 | 70 | |
OPM OPM% | 19.6 | -0.9 | 2.3 | -3.0 | 5.8 | 11.1 | 9.5 | 12.6 | 13.5 | 10.3 | 2.7 | 5.7 |
| -28 | -59 | 20 | 218 | 24 | 15 | 9 | 59 | 31 | 32 | 29 | 26 | |
Interest Expense Interest ExpenseCr | 294 | 336 | 302 | 0 | 4 | 51 | 32 | 32 | 16 | 13 | 9 | 11 |
Depreciation DepreciationCr | 145 | 141 | 133 | 130 | 118 | 109 | 87 | 55 | 33 | 42 | 43 | 42 |
PBT PBTCr | -296 | -544 | -399 | 69 | -70 | -95 | -57 | 55 | 92 | 122 | 10 | 42 |
| -17 | -48 | -46 | 0 | 0 | 0 | 0 | 0 | -3 | -10 | 0 | 0 | |
PAT PATCr | -279 | -495 | -353 | 69 | -70 | -95 | -57 | 55 | 95 | 131 | 11 | 42 |
Growth PAT Growth% | -41.6 | -77.5 | 28.8 | 119.7 | -200.4 | -36.7 | 40.3 | 197.1 | 72.1 | 38.0 | -91.9 | 16.5 |
NPM NPM% | -32.0 | -62.2 | -51.6 | 11.6 | -14.4 | -21.2 | -10.2 | 8.3 | 11.6 | 9.4 | 0.9 | 3.5 |
| -32.1 | -55.7 | -39.6 | 7.8 | -14.8 | -28.6 | -0.5 | 11.3 | 19.1 | 19.6 | 1.7 | 7.1 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 89 | 89 | 89 | 89 | 41 | 41 | 41 | 41 | 51 | 60 | 60 | 60 |
Reserves ReservesCr | -40 | -556 | -881 | -793 | 725 | 544 | 538 | 579 | 1,050 | 1,494 | 1,504 | 1,572 |
| 1,338 | 1,510 | 2,013 | 2,346 | 175 | 142 | 241 | 372 | 260 | 509 | 491 | 652 | |
| 2,475 | 2,212 | 1,905 | 1,436 | 519 | 442 | 222 | 165 | 124 | 15 | 203 | 368 | |
| 3,862 | 3,256 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,225 | 1,554 | 2,077 | 2,258 | 2,652 | |
| 1,251 | 675 | 679 | 767 | 569 | 550 | 398 | 501 | 791 | 1,098 | 929 | 955 | |
| 2,611 | 2,580 | 2,446 | 2,310 | 891 | 687 | 713 | 724 | 763 | 980 | 1,329 | 1,697 | |
| 3,862 | 3,256 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,225 | 1,554 | 2,077 | 2,258 | 2,652 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 89 | 89 | 89 | 89 | 41 | 41 | 41 | 41 | 51 | 60 | 60 | 60 |
Reserves ReservesCr | -40 | -556 | -881 | -793 | 725 | 544 | 538 | 579 | 1,050 | 1,494 | 1,504 | 1,572 |
| 1,338 | 1,510 | 2,013 | 2,346 | 175 | 142 | 241 | 372 | 260 | 509 | 491 | 652 | |
| 2,475 | 2,212 | 1,905 | 1,436 | 519 | 442 | 222 | 165 | 124 | 15 | 203 | 368 | |
| 3,862 | 3,256 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,225 | 1,554 | 2,077 | 2,258 | 2,652 | |
| 1,251 | 675 | 679 | 767 | 569 | 550 | 398 | 501 | 791 | 1,098 | 929 | 955 | |
| 2,611 | 2,580 | 2,446 | 2,310 | 891 | 687 | 713 | 724 | 763 | 980 | 1,329 | 1,697 | |
| 3,862 | 3,256 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,225 | 1,554 | 2,077 | 2,258 | 2,652 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 212 | 401 | 9 | 12 | 81 | 24 | 92 | 18 | 126 | 51 | 126 | |
| -1 | -176 | -28 | 45 | 167 | 67 | 113 | -31 | -312 | -36 | -277 | |
| -286 | -465 | 33 | 0 | -250 | -165 | -217 | 31 | 167 | 2 | 137 | |
Net Cash Flow Net Cash FlowCr | -76 | -240 | 15 | 57 | -2 | -74 | -11 | 18 | -19 | 17 | -14 |
Free Cash Flow Free Cash FlowCr | 211 | 392 | 3 | 5 | 77 | 23 | 238 | -8 | 61 | -102 | -255 |
CFO To PAT CFO To PAT% | -76.0 | -80.9 | -2.6 | 17.3 | -115.9 | -24.8 | -162.5 | 33.2 | 132.5 | 39.2 | 1,183.0 |
CFO To EBITDA CFO To EBITDA% | 124.3 | -5,331.4 | 58.5 | -66.0 | 287.4 | 47.4 | 174.0 | 21.9 | 113.8 | 35.6 | 374.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 212 | 401 | 9 | 12 | 81 | 24 | 92 | 18 | 126 | 51 | 126 | |
| -1 | -176 | -28 | 45 | 167 | 67 | 113 | -31 | -312 | -36 | -277 | |
| -286 | -465 | 33 | 0 | -250 | -165 | -217 | 31 | 167 | 2 | 137 | |
Net Cash Flow Net Cash FlowCr | -76 | -240 | 15 | 57 | -2 | -74 | -11 | 18 | -19 | 17 | -14 |
Free Cash Flow Free Cash FlowCr | 211 | 392 | 3 | 5 | 77 | 23 | 238 | -8 | 61 | -102 | -255 |
CFO To PAT CFO To PAT% | -76.0 | -80.9 | -2.6 | 17.3 | -115.9 | -24.8 | -162.5 | 33.2 | 132.5 | 39.2 | 1,183.0 |
CFO To EBITDA CFO To EBITDA% | 124.3 | -5,331.4 | 58.5 | -66.0 | 287.4 | 47.4 | 174.0 | 21.9 | 113.8 | 35.6 | 374.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 333 | 233 | 98 | 47 | 10,062 | 1,160 | 1,569 | 5,301 | 3,940 | 2,426 | 5,751 | |
Price To Earnings Price To Earnings | 0.7 | 33.9 | 57.5 | 8.8 | 73.5 | 134.7 | ||||||
Price To Sales Price To Sales | 0.4 | 0.3 | 0.1 | 0.1 | 22.4 | 2.1 | 2.4 | 6.5 | 2.8 | 2.0 | 4.7 | |
Price To Book Price To Book | 6.8 | -0.5 | -0.1 | -0.1 | 17.2 | 2.0 | 2.5 | 4.8 | 0.8 | 0.5 | 3.5 | |
EV To EBITDA EV To EBITDA | 17.7 | -363.3 | 151.7 | -101.2 | 210.3 | 26.7 | 22.4 | 46.7 | 27.0 | 78.9 | 89.4 | |
GPM GPM% | 40.6 | 37.5 | 34.3 | 36.6 | 39.6 | 35.1 | 29.9 | 28.7 | 29.2 | 25.2 | 20.4 | 20.4 |
OPM OPM% | 19.6 | -0.9 | 2.3 | -3.0 | 5.8 | 11.1 | 9.5 | 12.6 | 13.5 | 10.3 | 2.7 | 5.7 |
NPM NPM% | -32.0 | -62.2 | -51.6 | 11.6 | -14.4 | -21.2 | -10.2 | 8.3 | 11.6 | 9.4 | 0.9 | 3.5 |
ROCE ROCE% | -0.1 | -9.1 | -5.4 | 4.9 | -5.2 | -4.3 | -2.9 | 9.2 | 8.8 | 7.9 | 1.0 | 2.4 |
ROE ROE% | -569.1 | 106.2 | 44.5 | -9.9 | -9.1 | -16.3 | -9.8 | 8.9 | 8.6 | 8.4 | 0.7 | 2.6 |
ROA ROA% | -7.2 | -15.2 | -11.3 | 2.3 | -4.8 | -7.7 | -5.1 | 4.5 | 6.1 | 6.3 | 0.5 | 1.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 333 | 233 | 98 | 47 | 10,062 | 1,160 | 1,569 | 5,301 | 3,940 | 2,426 | 5,751 | |
Price To Earnings Price To Earnings | 0.7 | 33.9 | 57.5 | 8.8 | 73.5 | 134.7 | ||||||
Price To Sales Price To Sales | 0.4 | 0.3 | 0.1 | 0.1 | 22.4 | 2.1 | 2.4 | 6.5 | 2.8 | 2.0 | 4.7 | |
Price To Book Price To Book | 6.8 | -0.5 | -0.1 | -0.1 | 17.2 | 2.0 | 2.5 | 4.8 | 0.8 | 0.5 | 3.5 | |
EV To EBITDA EV To EBITDA | 17.7 | -363.3 | 151.7 | -101.2 | 210.3 | 26.7 | 22.4 | 46.7 | 27.0 | 78.9 | 89.4 | |
GPM GPM% | 40.6 | 37.5 | 34.3 | 36.6 | 39.6 | 35.1 | 29.9 | 28.7 | 29.2 | 25.2 | 20.4 | 20.4 |
OPM OPM% | 19.6 | -0.9 | 2.3 | -3.0 | 5.8 | 11.1 | 9.5 | 12.6 | 13.5 | 10.3 | 2.7 | 5.7 |
NPM NPM% | -32.0 | -62.2 | -51.6 | 11.6 | -14.4 | -21.2 | -10.2 | 8.3 | 11.6 | 9.4 | 0.9 | 3.5 |
ROCE ROCE% | -0.1 | -9.1 | -5.4 | 4.9 | -5.2 | -4.3 | -2.9 | 9.2 | 8.8 | 7.9 | 1.0 | 2.4 |
ROE ROE% | -569.1 | 106.2 | 44.5 | -9.9 | -9.1 | -16.3 | -9.8 | 8.9 | 8.6 | 8.4 | 0.7 | 2.6 |
ROA ROA% | -7.2 | -15.2 | -11.3 | 2.3 | -4.8 | -7.7 | -5.1 | 4.5 | 6.1 | 6.3 | 0.5 | 1.6 |
| Market CapitalizationMkt CapCr | 11,470 | 10,272 | 8,984 | 5,751 | 5,404 | 4,991 | 4,940 |
| Close PriceClose₹ | 548.20 | 1,598.60 | 990.70 | 960.40 | 184.12 | 620.15 | 90.15 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 41.03 | 75.80 | 34.99 | 134.70 | 26.61 | 28.18 | 26.28 |
| Price To SalesPS | 9.80 | 11.82 | 4.16 | 4.71 | 1.96 | 5.68 | 2.16 |
| RevenueRevenueCr | 1,170 | 869 | 2,161 | 1,221 | 2,751 | 879 | 2,286 |
| Revenue Growth TTMRev Gr TTM% | 4.0% | 13.4% | 20.1% | 26.8% | 23.0% | 30.2% | |
| PAT Growth TTMPAT Gr TTM% | -13.6% | 7.1% | 16.5% | 75.4% | -2.8% | 89.5% |
| Market CapitalizationMkt CapCr | 11,470 | 10,272 | 8,984 | 5,751 | 5,404 | 4,991 | 4,940 |
| Close PriceClose₹ | 548.20 | 1,598.60 | 990.70 | 960.40 | 184.12 | 620.15 | 90.15 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 41.03 | 75.80 | 34.99 | 134.70 | 26.61 | 28.18 | 26.28 |
| Price To SalesPS | 9.80 | 11.82 | 4.16 | 4.71 | 1.96 | 5.68 | 2.16 |
| RevenueRevenueCr | 1,170 | 869 | 2,161 | 1,221 | 2,751 | 879 | 2,286 |
| Revenue Growth TTMRev Gr TTM% | 4.0% | 13.4% | 20.1% | 26.8% | 23.0% | 30.2% | |
| PAT Growth TTMPAT Gr TTM% | -13.6% | 7.1% | 16.5% | 75.4% | -2.8% | 89.5% |